UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Experimental evaluation of commercial heat exchangers for use as PCM thermal storage systems

Applied energy, 2009-10, Vol.86 (10), p.2047-2055

2009

Volltextzugriff (PDF)

Immersive three-dimensional modeling augmented reality and virtual reality for enhanced visualization of the white matter pathways

Brain & spine, 2022, Vol.2, p.101375, Article 101375

2022

Volltextzugriff (PDF)

PO-2286 Nutritional interventions in acute radiation-induced diarrhoea in pelvic cancer: a systematic review

Radiotherapy and oncology, 2023-05, Vol.182, p.S2056-S2056

2023

Volltextzugriff (PDF)

The role of NMDA glutamate receptors in lung injury caused by chronic long-term intermittent hypobaric hypoxia

Brazilian journal of medical and biological research, 2023-01, Vol.56 (1), p.e12549-e12549

2023

Volltextzugriff (PDF)

Controlled graft copolymerization of lactic acid onto starch in a supercritical carbon dioxide medium

Carbohydrate polymers, 2014-12, Vol.114, p.149-156

2014

Volltextzugriff (PDF)

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

Tuberkuloz ve toraks, 2023-09, Vol.71 (3), p.273-280

2023

Volltextzugriff (PDF)

Synthesis and characterization of poly(glycerol-co-sebacate-co-ε-caprolactone) elastomers

Journal of tissue engineering and regenerative medicine, 2016-01, Vol.10 (1), p.E14-E22

2016

Volltextzugriff (PDF)

Supplementary Health Insurance in Turkey

Value in health, 2013-11, Vol.16 (7), p.A454-A454

2013

Volltextzugriff (PDF)

How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

Value in health, 2013-11, Vol.16 (7), p.A453-A454

2013

Volltextzugriff (PDF)

External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey

Value in health, 2014-05, Vol.17 (3), p.A30-A30

2014

Volltextzugriff (PDF)

Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey?

Value in health, 2013-05, Vol.16 (3), p.A257-A257

2013

Volltextzugriff (PDF)

Assessment of Palliative Care in Lung Cancer in Turkey

Medical principles and practice, 2017-01, Vol.26 (1), p.50-56

2017

Volltextzugriff (PDF)

The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey

Value in health, 2014-05, Vol.17 (3), p.A115-A116

2014

Volltextzugriff (PDF)

PHP120 - External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey

Value in health, 2014-05, Vol.17 (3), p.A30-A30

2014

Volltextzugriff (PDF)

PHP1 - How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

Value in health, 2013-11, Vol.16 (7), p.A453-A454

2013

Volltextzugriff (PDF)

PHP3 - Supplementary Health Insurance in Turkey

Value in health, 2013-11, Vol.16 (7), p.A454-A454

2013

Volltextzugriff (PDF)

The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs

Value in health, 2013-05, Vol.16 (3), p.A282-A282

2013

Volltextzugriff (PDF)

The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs

Value in health, 2013-05, Vol.16 (3), p.A281-A281

2013

Volltextzugriff (PDF)

The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

Value in health, 2013-05, Vol.16 (3), p.A285-A285

2013

Volltextzugriff (PDF)

The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey

Value in health, 2013-05, Vol.16 (3), p.A287-A288

2013

Volltextzugriff (PDF)

PHP75 - Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey?

Value in health, 2013-05, Vol.16 (3), p.A257-A257

2013

Volltextzugriff (PDF)

PCV78 - The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey

Value in health, 2014-05, Vol.17 (3), p.A115-A116

2014

Volltextzugriff (PDF)

PCV55 - The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs

Value in health, 2013-05, Vol.16 (3), p.A281-A281

2013

Volltextzugriff (PDF)

PCV78 - The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

Value in health, 2013-05, Vol.16 (3), p.A285-A285

2013

Volltextzugriff (PDF)

PCV58 - The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs

Value in health, 2013-05, Vol.16 (3), p.A282-A282

2013

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(35)
Tagungsberichte
(4)

Sprache

Englisch
(39)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(10)
Internal Medicine
(9)
Veterinary Sciences
(5)
Fading
(4)
Humans
(4)
Mimo
(4)
Technology
(4)
Animals
(3)
Engineering
(3)
Http://www.Fao.Org/aos/agrovoc#c_8013
(3)
Mobile Communication
(3)
Neoplasms
(3)
Relays
(3)
Turkey
(3)
Turquia
(3)
Turquie
(3)
Adult
(2)
Anxiety
(2)
Applied Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Experimental evaluation of commercial heat exchangers for use as PCM thermal storage systems

Immersive three-dimensional modeling augmented reality and virtual reality for enhanced visualization of the white matter pathways

PO-2286 Nutritional interventions in acute radiation-induced diarrhoea in pelvic cancer: a systematic review

The role of NMDA glutamate receptors in lung injury caused by chronic long-term intermittent hypobaric hypoxia

Controlled graft copolymerization of lactic acid onto starch in a supercritical carbon dioxide medium

Determining factors affecting the acceptability of spirometry: A survey study in a tertiary chest diseases center

Synthesis and characterization of poly(glycerol-co-sebacate-co-ε-caprolactone) elastomers

Supplementary Health Insurance in Turkey

How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey

Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey?

Assessment of Palliative Care in Lung Cancer in Turkey

The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey

PHP120 - External Reference Pricing (Erp) In Turkey And Its Effects On Countries That Refer To Turkey

PHP1 - How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

PHP3 - Supplementary Health Insurance in Turkey

The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs

The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs

The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey

PHP75 - Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey?

PCV78 - The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey

PCV55 - The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs

PCV78 - The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

PCV58 - The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs

Suchergebnisse filtern